About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Abcc9tm1Cfb
targeted mutation 1, Charles F Burant
MGI:2155916
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Abcc9tm1Cfb/Abcc9tm1Cfb involves: CD-1 MGI:2653868
hm2
Abcc9tm1Cfb/Abcc9tm1Cfb Not Specified MGI:3622096


Genotype
MGI:2653868
hm1
Allelic
Composition
Abcc9tm1Cfb/Abcc9tm1Cfb
Genetic
Background
involves: CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Abcc9tm1Cfb mutation (0 available); any Abcc9 mutation (101 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• increased spontaneous death observed at 6 weeks of age in males and at 10 weeks of age in females

growth/size/body
• weight gain begins to lag relative to that of wild-type mice after 6 weeks of age

homeostasis/metabolism
• at 10-12 weeks of age, fasted homozygotes show a small but significant reduction of serum glucose levels relative to wild-type mice
• however, no significant differences are noted in fasted serum electrolytes at 6-8 weeks of age or in fed or fasting serum insulin levels and fed or fasting serum triglyceride levels at 10-12 weeks of age relative to wild-type mice
• in response to i.p. injection of glucose (2 g/kg), homozygotes display a significantly improved glucose tolerance curve, with peak serum glucose levels of ~250 mg/dl at 30 min post-injection relative to 420 mg/dl in wild-type mice
• during in vivo hyperinsulinemic euglycemic clamp studies, homozygotes require a higher glucose infusion rate to maintain target serum glucose levels than wild-type mice
• in response to 0.5 U/kg of insulin challenge, homozygotes exhibit a more rapid and sustained decrease in serum glucose than wild-type mice, with 50% of mutants either succumbing to hypoglycemia or requiring glucose injections to restore glucose levels
• increased insulin action is intrinsic to skeletal muscle, as shown by a 59% increase in in vitro insulin-stimulated glucose uptake into the soleus muscle

muscle
• following incubation with insulin, male homozygotes show a 1.5-fold increase in in vitro glucose uptake into skeletal (soleus) muscle relative to wild-type males
• however, in the absence of insulin, in vitro glucose uptake into mutant skeletal muscle is similar to that in wild-type, indicating normal basal glucose transport

cellular
• following incubation with insulin, male homozygotes show a 1.5-fold increase in in vitro glucose uptake into skeletal (soleus) muscle relative to wild-type males
• however, in the absence of insulin, in vitro glucose uptake into mutant skeletal muscle is similar to that in wild-type, indicating normal basal glucose transport




Genotype
MGI:3622096
hm2
Allelic
Composition
Abcc9tm1Cfb/Abcc9tm1Cfb
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Abcc9tm1Cfb mutation (0 available); any Abcc9 mutation (101 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• by 30 weeks of age, 65% of males and 35% of females die suddenly

cardiovascular system
• exhibit repeated episodes of spontaneous ST segment elevation that are often followed by slow heart rate, however show normal baseline resting heart rate, PR intervals and QRS
• ST segment depression is seen during the recovery phase of the transient ischemic events
• do not show a drop in blood pressure with pinacidil administration or any response to glyburide as in wild-type
• seen in conscious 12- to 18-week old mice
• seen in conscious 12- to 18-week old mice
• glibenclamide-sensitive KATP current is absent in aortic smooth muscle cells
• exhibit transient, repeated episodes of coronary artery vasospasm
• calcium channel antagonists reduce coronary artery vasospasms

muscle
• glibenclamide-sensitive KATP current is absent in aortic smooth muscle cells





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory